In another study, the proliferation of Michigan Cancer Foundation‐7 (MCF‐7) breast cancer cells was halted time‐dependently by mangiferin's suppression of the cyclin‐dependent kinase 1 (CDK1)–cyclin Bl signaling pathway and subsequent G2/M phase cell‐cycle arrest. Here, CDK1 is linked to breast carcinoma.